{"id":"NCT02441283","sponsor":"AbbVie","briefTitle":"A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530","officialTitle":"A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy (ABT-493 and/or ABT-530) in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2015-06-22","primaryCompletion":"2019-10-15","completion":"2019-10-15","firstPosted":"2015-05-12","resultsPosted":"2020-09-21","lastUpdate":"2020-09-21"},"enrollment":384,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"ABT-493","otherNames":["Glecaprevir"]},{"type":"DRUG","name":"ABT-530","otherNames":["Pibrentasvir"]}],"arms":[{"label":"HCV-infected Participants","type":"NO_INTERVENTION"}],"summary":"This was a long-term follow-up study to evaluate the durability of sustained virologic response (SVR), persistence of direct-acting antiviral agent (DAA) resistance, and clinical outcomes for participants who received glecaprevir (ABT-493) and/or pibrentasvir (ABT-530) in prior AbbVie Phase 2 or 3 clinical studies for the treatment of chronic hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants Who Maintained a Sustained Virologic Response (SVR) Out of Those Who Achieved SVR12 in a Prior Study With an ABT-493- and/or ABT-530-containing Regimen","timeFrame":"From the end of treatment in the previous study up to 3 years post-treatment","effectByArm":[{"arm":"HCV-infected Participants","deltaMin":99.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":42,"countries":["United States","Australia","Belgium","Canada","Germany","New Zealand","Puerto Rico","United Kingdom"]},"refs":{"pmids":["35220658"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":377},"commonTop":[]}}